Boehringer Ingelheim Posted September 14, 2026

Director, BD&L (China for China) (Shanghai, China, Shanghai)

Shanghai, China Type not listed
Notify me about similar jobs

Boehringer Ingelheim is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

About Innovation Unit China

Innovation Unit China (China R&D Center) is a strategic innovation hub within Boehringer Ingelheim’s global R&D network, established to harness China’s rapidly evolving scientific capabilities and vibrant innovation ecosystem. By integrating Experimental Medicine, External Innovation, Development CMC, and Clinical Pharmacology & Non-clinical Safety Science, IU China connects promising science with early development expertise to accelerate high-potential opportunities, contribute to the global pipeline, and help accelerate breakthrough therapies for patients in China and around the world.

Role & Responsibility:

- Optimize Boehringer China's long-term profitable growth by establishing external partnerships aligned with HP strategy

- Identify and develop external licensing and partnerships opportunities with cross-functional collaboration from TA, X-TA Strategy, MED, Cannel Solution, FIN, HAMA, Compliance & Legal

- Lead cross-functional project teams to contract execution & transition completion for external partnerships projects, incl. license-in/out and commercial partnerships following BI external partnerships procedures

- Develop and continuously optimize the external partnerships process, including opportunity intake, evaluation criteria, governance mechanism, decision-making workflow and post-deal transition approach, to ensure consistency, efficiency and strategic alignment.

• Define clear process steps, roles and responsibilities across the partnership lifecycle.

• Set up standardized templates, evaluation tools and governance forums to support effective decision-making.

• Regularly review process effectiveness and identify improvement opportunities based on business needs and project feedback.

- Identify, screen and develop business opportunities in line with HP Strategy, therapeutic area priorities and China business needs, including potential licensing, collaboration, co-development, commercialization and other strategic partnership models.

• Conduct market landscaping, competitor monitoring and industry trend analysis to identify potential opportunity areas.

• Screen and prioritize targets based on strategic fit, scientific value, commercial potential, differentiation and feasibility.

• Prepare initial opportunity assessments and recommendations for internal discussion and leadership review.

- Lead cross-functional external partnership projects end-to-end, including opportunity search and assessment, strategic fit analysis, financial modeling and valuation, value proposition development, deal structure design, due diligence coordination, negotiation support, contract execution and smooth handover to relevant business owners after deal closure.

• Coordinate cross-functional due diligence workstreams and ensure timely input from relevant subject matter experts.

• Develop project plans, track key milestones, identify risks and drive issue resolution throughout the project lifecycle.

• Support business case development, deal discussion, negotiation preparation and internal approval processes.

- Build and maintain a strong external network with potential partners, industry associations, innovation platforms, investment communities, consulting firms and other external partnership-related stakeholders to proactively capture market trends and collaboration opportunities.

• Establish regular engagement channels with potential partners and ecosystem stakeholders.

• Represent the organization in selected industry events, partnering discussions and external forums as appropriate.

• Maintain ongoing relationship mapping and follow-up plans to support long-term partnership development.

- Manage external suppliers and service providers, including identifying, evaluating, selecting, onboarding, monitoring and maintaining consulting firms, market research agencies and other vendors to ensure quality delivery, compliance requirements and cost effectiveness.

• Define project briefs, scope of work, deliverables, timelines and quality expectations for external vendors.

• Coordinate vendor selection, contracting, purchase order and compliance-related processes in collaboration with relevant internal functions.

• Monitor vendor performance, review outputs and ensure deliverables are actionable, business-relevant and completed on time.

- Establish, maintain and regularly update the external partnership database, including target companies, assets, technologies, partnership status, key contacts, assessment outcomes and follow-up actions, to support pipeline tracking and management decision-making.

• Collect and structure information from market research, external meetings, internal discussions and project assessments.

• Track opportunity status, key milestones, ownership, next steps and decision records in a consistent format.

• Generate regular pipeline updates, summary reports and management dashboards to support prioritization and follow-up.

- Build effective cross-functional collaboration with TA,X-TA Strategy, Medicine, Finance, Legal, Compliance, HR, Corporate Affairs, Commercial Support, HAMA, TCM Leadership Team and other corporate functions to ensure alignment, timely input and high-quality execution of partnership projects.

• Facilitate regular communication and alignment meetings with internal stakeholders throughout the partnership process.

• Translate business needs into clear project requirements and ensure functional inputs are integrated into project deliverables.

• Escalate key risks, decisions and resource needs in a timely manner to support effective governance and execution.

Requirements:

Minimum 10 years of related experience in a pharmaceutical company in Business Development, Marketing, or a business consultancy

Experienced in long-term strategic business planning and analysis

Strong selling, negotiation, collaboration, and project management skills

Deep knowledge of the Chinese market and customers

High resiliency, agility, and intrapreneurship

Job details

Seniority
Director
Function
BD&L & Strategic Planning
Therapeutic area
Not listed
Location
Shanghai, China
Employment type
Not listed

How this role compares

Computed from every other active BD&L & Strategic Planning role in our database, not just this employer's listings.

We currently track 118 comparable Director BD&L & Strategic Planning roles across 53 biopharma companies.

118Comparable roles tracked
102Currently active
53Companies hiring similar roles
17Countries represented

Salary context

41 of 118 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject Not listed on this posting
Lowest disclosed · Principal Scientist II, Translational Biomarker Strategy Lead · Novartis $114,100/yr – $211,900/yr
Highest disclosed · Sr Director, Corporate Strategy & Projects · Gilead Sciences, Inc. $261,375/yr – $338,250/yr
Peer group range $163,000 – $299,813 (median $235,450)

Where these roles are based

Top locations among the 118 comparable roles

United States71
China16
Japan5
United Kingdom4
Switzerland3
Germany3

+ 11 more countries

Seniority mix

118 of 118 peers have a known seniority level

Director84
Senior Director27
Principal7

Therapeutic area mix

23 of 118 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology7
Immunology7
Neuroscience5
Dermatology & Aesthetics2
Respiratory1
Vaccines & Infectious Disease1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

60%similar
Boehringer Ingelheim Shanghai, China Director
Same function Same seniority Same country
60%similar
AbbVie Shanghai, Shanghai Director
Same function Same seniority Same country
60%similar
Johnson & Johnson Shanghai, China Director
Same function Same seniority Same country
60%similar
H. Lundbeck Shanghai, China Director
Same function Same seniority Same country
60%similar
SACIC SH Shanghai, China Director
Same function Same seniority Same country
60%similar
Novo Nordisk Beijing, China Director
Same function Same seniority Same country

Notify me about similar jobs

Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.

Or follow a whole field: get every new BD&L & Strategic Planning job in China, and choose locations and companies.

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

60%
Investment Director, Venture Fund (Shanghai, China)
Boehringer Ingelheim · Shanghai, China · Director
Function Therapeutic area Seniority Country
60%
Director, Neuroscience External Innovation (APAC)
Johnson & Johnson · Shanghai, China · Director
Function Therapeutic area Seniority Country
60%
China Search & Evaluation Director
SACIC SH · Shanghai, China · Director
Function Therapeutic area Seniority Country
60%
Director, Commercial Strategy (Beijing, Beijing, CN)
Novo Nordisk · Beijing, China · Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.